Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hein J Boot

Showing results (21-30 of 32) with videos related to

Pageof 4
Sort By:
Virology|August 16, 2003
Homotypic interactions of the infectious bursal disease virus proteins VP3, pVP2, VP4, and VP5: mapping of the interacting domainsMirriam G J Tacken, Patricia A J Van Den Beuken, Ben P H Peeters, et al.
Plos One|April 13, 2016
Genetic Diversity in the Major Capsid L1 Protein of HPV-16 and HPV-18 in the NetherlandsAudrey J King, Jan A Sonsma, Henrike J Vriend, et al.
Plos One|April 29, 2016
Correction: Genetic Diversity in the Major Capsid L1 Protein of HPV-16 and HPV-18 in the NetherlandsAudrey J King, Jan A Sonsma, Henrike J Vriend, et al.
Plos One|May 3, 2013
Patterns of human papillomavirus DNA and antibody positivity in young males and females, suggesting a site-specific natural course of infectionHenrike J Vriend, Johannes A Bogaards, Fiona R M van der Klis, et al.
European Journal of Public Health|March 31, 2012
Hepatitis C virus seroprevalence in the NetherlandsHenrike J Vriend, Eline L M Op de Coul, Thijs J W van de Laar, et al.
Plos One|November 16, 2012
Changes in antibody seroprevalence of seven high-risk HPV types between nationwide surveillance studies from 1995-96 and 2006-07 in The NetherlandsMirte Scherpenisse, Madelief Mollers, Rutger M Schepp, et al.
Vaccine|September 11, 2012
Seroprevalence of seven high-risk HPV types in The NetherlandsMirte Scherpenisse, Madelief Mollers, Rutger M Schepp, et al.
Vaccine|July 17, 2007
Assessing the introduction of universal human papillomavirus vaccination for preadolescent girls in The NetherlandsHein J Boot, Iris Wallenburg, Hester E de Melker, et al.
Vaccine|September 13, 2008
Air travel as a risk factor for introduction of measles in a highly vaccinated populationRobert S van Binnendijk, Susan Hahné, Aura Timen, et al.
Vaccine|March 3, 2012
Mumps vaccine effectiveness in primary schools and households, the Netherlands, 2008Bianca E P Snijders, Alies van Lier, Jan van de Kassteele, et al.
Pageof 4

Showing results (21-30 of 32) with videos related to

Sort By:
Pageof 4
Virology|August 16, 2003
Homotypic interactions of the infectious bursal disease virus proteins VP3, pVP2, VP4, and VP5: mapping of the interacting domainsMirriam G J Tacken, Patricia A J Van Den Beuken, Ben P H Peeters, et al.
Plos One|April 13, 2016
Genetic Diversity in the Major Capsid L1 Protein of HPV-16 and HPV-18 in the NetherlandsAudrey J King, Jan A Sonsma, Henrike J Vriend, et al.
Plos One|April 29, 2016
Correction: Genetic Diversity in the Major Capsid L1 Protein of HPV-16 and HPV-18 in the NetherlandsAudrey J King, Jan A Sonsma, Henrike J Vriend, et al.
Plos One|May 3, 2013
Patterns of human papillomavirus DNA and antibody positivity in young males and females, suggesting a site-specific natural course of infectionHenrike J Vriend, Johannes A Bogaards, Fiona R M van der Klis, et al.
European Journal of Public Health|March 31, 2012
Hepatitis C virus seroprevalence in the NetherlandsHenrike J Vriend, Eline L M Op de Coul, Thijs J W van de Laar, et al.
Plos One|November 16, 2012
Changes in antibody seroprevalence of seven high-risk HPV types between nationwide surveillance studies from 1995-96 and 2006-07 in The NetherlandsMirte Scherpenisse, Madelief Mollers, Rutger M Schepp, et al.
Vaccine|September 11, 2012
Seroprevalence of seven high-risk HPV types in The NetherlandsMirte Scherpenisse, Madelief Mollers, Rutger M Schepp, et al.
Vaccine|July 17, 2007
Assessing the introduction of universal human papillomavirus vaccination for preadolescent girls in The NetherlandsHein J Boot, Iris Wallenburg, Hester E de Melker, et al.
Vaccine|September 13, 2008
Air travel as a risk factor for introduction of measles in a highly vaccinated populationRobert S van Binnendijk, Susan Hahné, Aura Timen, et al.
Vaccine|March 3, 2012
Mumps vaccine effectiveness in primary schools and households, the Netherlands, 2008Bianca E P Snijders, Alies van Lier, Jan van de Kassteele, et al.
Pageof 4